MicroRNA Markers in Head and Neck Cancers

Running, not enrolling

Conditions studied: Squamous Cell Carcinoma of Head and Neck

In brief

The purpose of this study is to investigate the presence of miRNA markers in saliva, blood, FNA and tissue specimens in patients with and without head and neck cancer and evaluate whether these miRNA markers can provide prognostic or diagnostic clinical significance in the treatment of head and neck cancer patients.

Key facts

Study ID

NCT04305366

Run by

University of Colorado, Denver

People needed

225

Starts

2012-11-16

Expected to finish

2027-02-01

Last updated by the study team

2026-02-24

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects between the ages of 18 and 100
• Patients who are seen and evaluated by a provider within the adult ENT clinic at University of Colorado Hospital
• Patients that present with a current or past diagnosis of head and neck cancer -OR-Patients undergoing tonsillectomy or sleep surgery as standard of care (control group)

You may not qualify if…

• Under the age of 18 or over the age of 100
• Unwilling to participate

Where it is running

• University of Colorado Cancer Center — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.